Evidence map›Paper›PMID 41430049›Full record

ArticleNature communications2025

Computational design of allulose-responsive biosensor toolbox for auto-inducible protein expression and CRISPRi mediated dynamic metabolic regulation.

Qianzhen Dong, Peng Chen, Zhiru Guo, Hongli Wei, Yan Zeng, Jingyu Zhang, Yan Men, Weidong Liu, Yuanxia Sun, Jiangang Yang

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qianzhen DongTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.ORCID http://orcid.org/0009-0006-4073-5783
Peng ChenTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Zhiru GuoTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Hongli WeiTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Yan ZengTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Jingyu ZhangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.ORCID http://orcid.org/0009-0006-5008-6051
Yan MenTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Weidong LiuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.ORCID http://orcid.org/0000-0001-7954-7700
Yuanxia SunTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China. sun_yx@tib.cas.cn.ORCID http://orcid.org/0000-0002-8160-4564
Jiangang YangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China. yang_jg1@tib.cas.cn.ORCID http://orcid.org/0000-0001-9463-8862

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32271545
6 · The paper itself

Abstract

Biosensors based on transcription factors (TFs) have shown extensive applications in synthetic biology. Due to the complex multi-domain structure of effector-TF-DNA, computational design of TFs remains a challenge. Here, we present the successful structure-guided computational design of the access tunnel, ligand binding, allosteric transition process for an allulose-responsive PsiR. It enables a 20-fold increase in sensitivity, reducing the EC

Indexed as

Biosensing TechniquesCRISPR-Cas SystemsTranscription FactorsEscherichia coliGlucoseSynthetic BiologyGlucoseTranscription Factors

Identifiers

PMID41430049
PMCPMC12748958

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.